OCULAR THERAPEUTIX, INC
OCULAR THERAPEUTIX, INC (OCUL) is a publicly traded company in the Unknown sector. Across all available filings, 35 corporate insiders have executed 226 transactions totaling $113.9M, demonstrating a bearish sentiment with -$35.9M in net insider flow. The most recent transaction on Feb 23, 2026 involved a sale of 1,759 shares valued at $14.6K.
OCUL Insider Activity Summary
Who Is Buying OCUL Stock?
No significant insider buying has been recorded for OCUL in the recent period.
Who Is Selling OCUL Stock?
No significant insider selling has been recorded for OCUL in the recent period.
Is OCULAR THERAPEUTIX, INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for OCUL is bearish with an Insider Alignment Score of 34/100 and a net flow of -$35.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
OCUL Frequently Asked Questions
Understanding OCUL Insider Activity
Insider trading at OCULAR THERAPEUTIX, INC (OCUL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 35 insiders are actively trading OCUL stock, having executed 226 transactions in the past 90 days. The most active insider is Life Sciences Fund IV Strategic Partners, L. P. Sv (Executive), who has made 4 transactions totaling $24.6M.
Related Tools
Track OCULAR THERAPEUTIX, INC Insider Activity
Get notified when executives and directors at OCUL file new Form 4 transactions